Read In Focus
ORWH’s In Focus Publication Explores Chronic Debilitating Conditions
The latest issue of Women’s Health in Focus at NIH explores chronic debilitating conditions affecting women—from arthritis, cancer, and diabetes to anxiety, depression, and PTSD.
ORWH Recognizes Breast Cancer Awareness Month
Breast cancer is the second most common cancer among American women. Lower your risk of developing breast cancer by viewing resources developed by the CDC.
ORWH's E-Learning Courses
Gain an up-to-date understanding of sex and gender influences on health and disease and NIH requirements on factoring sex as a biological variable into research designs through three online courses.
ORWH Women, Science, and the Impact of COVID-19 Webpage
This webpage describes: (1) NIH efforts to ensure that research on COVID-19 appropriately incorporates the consideration of sex and gender influences; (2) the pandemic’s effects on the careers of women in biomedical and other STEMM fields and how NIH is offering support; and (3) the NIH-Wide Strategic Plan for COVID-19 Research and how it intersects with ORWH’s mission areas.
Janine Austin Clayton, M.D., FARVO
Janine Austin Clayton, M.D., FARVO, was appointed Associate Director for Research on Women’s Health and Director of the Office of Research on Women’s Health at the National Institutes of Health (NIH) in 2012. Dr. Clayton has strengthened NIH support for research on diseases, disorders, and conditions that affect women. She is the architect of the NIH policy requiring scientists to consider sex as a biological variable across the research spectrum, including research designs, analyses, and reporting in vertebrate animal and human studies. The policy serves as the keystone of NIH's initiative to enhance research reproducibility, rigor, and transparency.
Featured NIH-Wide Resources & Initiatives
A public-private partnership to develop a coordinated research strategy to speed the most promising COVID-19 vaccines and treatments.
A new science agency proposed by President Joseph Biden as part of NIH to drive biomedical breakthroughs and provide transformative solutions for all patients.
A research effort to revolutionize how we improve health and treat disease.
A bold venture to help identify new treatments and cures for diseases.
An initiative to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.
NIH does not tolerate pervasive or severe harassment of any kind, including sexual harassment.
Trans-agency effort to speed scientific solutions to stem the national opioid crisis.
NIH-supported research has had a major positive impact on nearly all of our lives.
A new research initiative to understand, prevent, and treat the long-term effects of COVID-19.
Learn more about NIH’s efforts to end structural racism in biomedical research through the UNITE initiative.
Learn about participating in clinical trials and where to find them.
Important initiatives aimed at improving medical research.